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Abstract
Background: Although Haemophilus influenzae type b (Hib), Staphylococcus aureus and Moraxella catarrhalis are
important causes of invasive and mucosal bacterial disease among children, co-carriage with Streptococcus
pneumoniae during infancy has not been determined in West Africa.
Methods: Species specific PCR was applied to detect each microbe using purified genomic DNA from 498
nasopharyngeal (NP) swabs collected from 30 Gambian neonates every two weeks from 0 to 6 months and bi-
monthly up to 12 months.
Results: All infants carried S. pneumoniae, H. influenzae and M. catarrhalis at several time points during infancy.
S.pneumoniae co-colonized the infant nasopharynx with at least one other pathogen nine out of ten times. There
was early colonization of the newborns and neonates, the average times to first detection were 5, 7, 3 and 14
weeks for S. pneumoniae, H. influenzae, M. catarrhalis and S. aureus respectively. The prevalence of S. pneumoniae,
H. influenzae and M. catarrhalis increased among the neonates and exceeded 80% by 13, 15 and 23 weeks
respectively. In contrast, the prevalence of S. aureus decreased from 50% among the newborns to 20% amongst
nine-week old neonates. S. pneumoniae appeared to have a strong positive association with H. influenzae (OR 5.03;
95% CI 3.02, 8.39; p < 0.01) and M. catarrhalis (OR 2.20; 95% CI 1.29; p < 0.01) but it was negatively associated with
S. aureus (OR 0.53; 95% CI 0.30, 0.94; p = 0.03).
Conclusion: This study shows early acquisition and high co-carriage of three important respiratory pathogens with
S. pneumoniae in the nasopharyngeal mucosa among Gambian neonates and infants. This has important potential
implications for the aetiology of respiratory polymicrobial infections, biofilm formation and vaccine strategies.
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Background
An astounding 83% of childhood deaths (< 5 years)
between 1970 and 2009 occurred in Asia and sub-
Saharan Africa, sharply contrasted with less than 1%
which occurred in high-income nations [1]. Invasive bac-
terial disease (IBD) such as pneumonia, meningitis and
bacteraemia contribute to the disparity in childhood
mortality in developing and developed countries [2,3].
18% of the estimated eight million childhood deaths (< 5
years) which occurred worldwide in 2008 were attributed
to pneumonia, making it the single commonest cause of
death in the under five year olds [4].
Approximately 50% of the severe pneumonia cases in
developing countries are attributed to Streptococcus
pneumoniae and Haemophilus influenzae type b (Hib) in
areas where the vaccine is not widely available [5]. Non-
typeable strains of H. influenzae (NtHi) are associated
with otitis media (OM), community acquired pneumonia
and other IBD among vulnerable populations [6-8]. OM
is the most common bacterial infectious disease amongst
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children [9] and up to 20% of acute OM episodes are
caused by Moraxella catarrhalis [10]. In the Gambia,
pneumococcal nasopharyngeal carriage occurs rapidly
after birth and carriage exceeds 80% in infants [11]. Not
surprisingly, S. pneumoniae is also the leading cause of
IBD [12], with the highest prevalence occurring in
infancy. S. pneumoniae and Staphylococcus aureus
accounted for 45.2% and 18.3% respectively of bacterae-
mia cases in a study amongst hospitalised patients in the
Gambia with a median age of 2 years (range 2 months to
80 years) [13].
The nasopharynx is an important reservoir of commen-
sal and pathogenic microbes which can migrate to the
sinuses, middle ear and lower respiratory tract and invade
the blood system. Nasopharyngeal carriage is thought to
be the main source of transmission of pathogens across
individuals [14,15]. Although the specific mechanisms
are poorly understood, attachment to the nasopharyngeal
epithelial surface is thought to be an essential step in the
development of mucosal and invasive disease [16,17].
The epidemiology, transmission and nasopharyngeal car-
riage of S. pneumoniae have been studied in the Gambia
[11,13,15,18]. However co-carriage of S. pneumoniae
with H. influenzae, S. aureus and M. catarrhalis has not
been described in West Africa.
The seven-valent pneumococcal polysaccharide-
diphtheria CRM197 protein conjugate vaccine (PCV-7)
markedly reduces the carriage of vaccine serotypes and
decreases the incidence of vaccine serotype invasive dis-
ease, making it a remarkable public health success story
[19]. However, the long term effectiveness of PCV-7 also
depends on the emergence of serotype and species repla-
cement disease as the vacant niche is replenished by non-
vaccine pneumococcal serotypes or possibly other
respiratory pathogens that share the nasopharyngeal
niche [20,21].
This study set out to determine the co-carriage of H.
influenzae, S. aureus and M. catarrhalis with S. pneumo-
niae in the nasopharynx amongst PCV-7 naïve infants
using PCR-based methods.
Methods
Study site and sample collection
Nasopharyngeal (NP) swabs were collected from infants
from the Western Region of the Gambia after obtaining
parental informed consent as previously described by Hill
et al., 2008 [11]. Approval to conduct this study was
sought from the MRC, The Gambia Scientific Coordinat-
ing Committee and the Joint MRC & Gambian Govern-
ment Ethics Committee. NP swabs were collected prior
to the introduction of PCV-7. NP swabs were collected
by using sterile calcium alginate fibre tipped swabs with
aluminium shafts (Fisher Brand® , USA), placed in vials
containing Skim milk-tryptone-glucose-glycerol (STGG)
transport medium and stored at -70°C up to the time this
study was conducted. Thirty infants from which 498 NP
swabs (n = 16 NP swabs/infant) were selected from a lar-
ger cohort of 236 subjects on the basis that they had
complete or nearly complete data sets collected accord-
ing to the study design as described in [11]. The expected
number of NP swabs per infant was 17 however; the
average number of NP swabs amongst the infant selected
was 16.6. Each subject had the first NP swab collected
within a week of birth, bi-weekly for the first 6 months
and then bi-monthly for another 6 months.
DNA isolation
The NP swabs in STGG and stored at -70°C were thawed
at room temperature (25°C) and vortexed for approxi-
mately 10-20 s. 100 μL were centrifuged at 5 000 × g for
10 minutes and the pellet was resuspended in 20 mg/mL
lysozyme in lysis buffer (20 mM Tris-Cl, pH 8.0, 2 mM
sodium EDTA, 1.2% Triton® X-100). DNA was extracted
using the DNeasy Blood & Tissue Kit® (QIAGEN, UK),
following the manufacturer’s Gram positive protocol.
DNA was eluted in 100 μL of elution buffer and stored at
-20°C. Extractions were done in batches of 24 including a
negative control to which DNAse/RNase free water was
added and a positive control to which a fresh S. pneumo-
niae cell suspension (1 × 104 cells/mL) was added.
PCR detection of pathogens
PCR reactions were carried out in 25 μL reaction volumes
consisting 2.5 μL (10 ng) of purified genomic DNA, 1}
Green GoTaq® reaction buffer with 1.5 mM MgCl2, 1.0 U
GoTaq Polymerase (Promega, UK), each deoxynucleoside
triphosphate at 0.2 mM (dNTP) (QIAGEN, UK). The gene
targets and primer information specific for each microbe
are described below. PCR controls were purified genomic
DNA (20 ng/μL) of the following clinical isolates; S. pneu-
moniae, S. aureus, Hib, NtHi, M. catarrhalis, Pseudomonas
aeruginosa, Escherichia coli, Group A Streptococcus,
Group B Streptococcus, N. meningitidis, Citrobacter freun-
dii, Shigella flexneri and coagulase negative Staphylococ-
cus. Thermal cycling was performed in the Gradient Palm-
Cycler™ (Corbett Life Sciences, UK) as follows, 95°C for
2 minutes, followed by 35 cycles of 95°C for 30 seconds,
60°C for 30 seconds and 72°C for 45 seconds and a final
extension of 72°C for 10 minutes.
Detection of S. pneumoniae was carried out using pri-
mers that target the capsular polysaccharide synthesis gene
locus A, (cpsA), cpsAf:5’-GCAGTACAGCAGTTTGT
TGGACTGACC-3’ and cpsAr:5’-GAATATTTTCATTAT-
CAGTCCCAGTC-3’ [22]. M. catarrhalis detection was
done using primers that target the outer membrane protein
copB gene, copBf:5’-GTGAGTGCCGCTTTTACAACC-3’
and copBr:5’-TGTATCGCCTGCCAAGACAA-3’ [23].
S. aureus was detected using primers that target the
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Thermonuclease (Tnase) encoding gene (nuc), nucf:5’-
GCGATTGATGGTGATACGGTT-3’5 and nucr:5’-AGC-
CAAGCCTTGACGAACTAAAGC-3’ [24]. H. influenzae
detection was done using primers that target the
Outer membrane lipoprotein P2 (OmpP2), ompP2f:5’-
GGTGCATTCGCAGCTTCAG-3’ and ompP2r:5’-
GATTGCGTAATGCACCGTGTT-3’[25]. Capsule detec-
tion and typing of Hib were carried using the
oligonucleotides described by Howie et al. [26].
16S PCR detection was carried out on NP swabs that did
not yield any of the pathogens assayed using the following
primers: 338f-5’-ACTCCTACGGGNGGCNGCA-3’ and
1046r-5’-CACGAGCTGACGACANCCATGCANCACC-
3’. The presence of PCR inhibitors was determined by
spiking 20 μL of the NP swab genomic DNA with 10 ng of
S. pneumoniae DNA. 16S rRNA gene PCR was conducted
as described above on samples that were negative for all
four pathogens. 5 μL of PCR product were loaded on 2%
agarose gels stained with ethidium bromide and analyzed
by gel electrophoresis in 1x TAE buffer (40 mM Tris,
20 mM of glacial acetic acid, 1 mM EDTA, pH 8.0) for
60 min at 100 V. Gel images were recorded and the sizes
of the PCR products were confirmed by comparison with
the molecular size standard HyperLadder II (Bioline, UK).
Statistical Analysis
Results of the organism specific PCR assays were recorded
as presence/absence outcomes and all the statistical ana-
lyses were carried out in STATA release 11 (StataCorp LP,
USA). The point prevalence of each pathogen was deter-
mined for the 16 age strata ranging from (1, 3, 5, 7,
9 weeks up to 27 weeks and then 35, 43 and 51 weeks).
Logistic regression was used to determine associations
between carriage of S. pneumoniae and the presence of
each of the other three pathogens. Confounding factors in
the adjusted model included age, ethnic group, sex, anti-
biotic treatment and type of feeding [27]. Sixteen to seven-
teen samples were collected per infant; hence, to account
for correlations of response variables from the same infant,
subject identity was entered as a random effect. Log likeli-
hood Ratio Tests were performed to determine the contri-
bution of each pathogen to the model. Kaplan-Meier
survivor function was used to conducted time to first
detection for each of the microbes.
Results
Species specific PCR was applied to detect four patho-
gens in 498 NP swabs collected from 30 children in the
first year of life (n = 16.6NP swabs/infant). At least one
pathogen was detected in 473 (95%) of the nasopharyn-
geal swabs. The presence of bacteria was confirmed by
16S rRNA gene PCR for 15 (3%) of the nasopharyngeal
swabs that were negative for all four pathogens. Amplifi-
cation of spiked NP swab DNA contraindicated the
presence of inhibitors in the 5 (2%) NP swabs which
were negative for any of the pathogens and the 16S
rRNA gene.
High co-carriage of S. pneumoniae and respiratory
pathogens
Of the 391 NP swabs in which S. pneumoniae was found,
it was the only pathogen detected in 25 (6%) and it was
detected with at least one other pathogen in 366 NP swabs
(94%). S. pneumoniae was found with one, two and three
pathogens in 102 (26%), 228 (58%) and 36 (9%) 391 NP
swabs respectively. During infancy, the average carriage
prevalence for each of the pathogens was as follows;
S. pneumoniae 78% (95CI: 76%, 83%), M. catarrhalis 71%
(95CI: 67%, 75%), H. influenzae 70% (95CI: 65%, 74%) and
S. aureus 20% (95CI: 16%, 24%). Carriage of both S. pneu-
moniae and H. influenzae was below 30% in the first week
but increased rapidly as the infants got older, exceeding
90% between 15 and 19 weeks respectively (Figure 1).
M. catarrhalis carriage was 57% in the first week and
increased gradually to above 80% by 21 weeks. In contrast,
S. aureus carriage was 50% in the first week and
rapidly fell to 10% by 9 weeks and remained low thereafter
(Figure 1). The average prevalence of encapsulated
H. influenzae was 7% (95CI: 4.6%, 9.2%) and Hib had aver-
age prevalence of 0.7% (95CI: 0.5%, 0.9%) in the NP swabs
assayed (Figure 1).
Early acquisition of S. pneumoniae and respiratory
pathogens
The average times to first detection of S. pneumoniae, H.
influenzae, M. catarrhalis and S. aureus were 5, 7, 3 and
14 weeks respectively. By 129 days, 142 days and 149 days
all the infants had carried M. catarrhalis, S. pneumoniae
and H. influenzae at least once respectively (Figure 2).
Within the first 30 days, more than 75% of the infants had
acquired S. aureus at least once, (Figure 2); however, this
pathogen was not detected in any of the NP swabs from 5
(17%) of the infants. 25 (83%) of the samples collected
soon after birth (< 6 days) had at least one pathogen
detected, see Figure 3.
Associations between S. pneumoniae and three
respiratory pathogens
Logistic regression modelling was used to determine the
univariate and adjusted associations between S. pneumo-
niae carriage and the other respiratory pathogens. The
adjusted model included the following confounding fac-
tors; age, ethnic group, sex, antibiotic treatment, type of
feeding and weight [11,27]. There was a significant positive
interaction between colonization with S. pneumoniae and
H. influenzae in univariate analysis (OR 5.03; 95% CI 3.02,
8.39; p < 0.01) and the adjusted analysis OR 2.02; 95% CI
1.04, 3.91; p = 0.04). A significant positive association was
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Figure 1 Carriage of S. pneumoniae and three respiratory pathogens in the first year of life. The point prevalence of S. pneumoniae and
three respiratory in the nasopharynx among 30 infants followed-up from birth to one year (A). The average prevalence of H. influenzae,
encapsulated H. influenzae and Hib in the nasopharynx among 30 infants followed-up from birth to one year (B).
Figure 2 Survival curve for time to first detection of S. pneumoniae and three respiratory pathogens among 30 infants followed-up
from birth to one year.
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found between S. pneumoniae and M. catarrhalis in uni-
variate analysis (OR 2.20; 95% CI 1.29; p < 0.01) but not in
the adjusted analysis (OR 1.40; 95% CI 0.72, 2.71; p =
0.33). A significant negative correlation was found between
S. pneumoniae and S. aureus, (OR 0.53; 95% CI 0.30, 0.94;
p = 0.03) but not after the adjusted analysis (OR 1.33; 95%
CI 0.59, 3.02; p = 033).
Discussion
For the first time in West Africa, the nasopharyngeal car-
riage and co-occurrence of S. pneumoniae with respiratory
pathogens, H. influenzae, S. aureus and M. catarrhalis
detected by PCR amongst PCV naive infants is described.
Nine out of ten times, S. pneumoniae was co-carried with
at least one other pathogen, most often H. influenzae and
or M. catarrhalis (Figure 3). Multiple colonisation of the
nasopharynx may have important clinical significance with
regards to biofilm formation, polymicrobial infections and
antibiotic resistance [28,29].
Here we report very early onset of colonisation similar
to reports from high risk populations (Figure 1 and 2)
[28,30]. 83% of the nasopharyngeal samples collected
within a week of birth had between one and four patho-
gens detected (Figure 3) and the time to first acquisition
was less than 8 weeks for of S. pneumoniae, H. influenzae
and M. catarrhalis. In a culture-based study, Watson et al.
[28] showed that by 6 months, 72%, 69% and 60% of rural
Aboriginal infants from Western Australia had acquired
M. catarrhalis, S. pneumoniae and H. influenzae respec-
tively. In another culture-based study, M. catarrhalis
Figure 3 Heatmap showing co-carriage of S. pneumoniae with three respiratory pathogens in the nasopharynx among 30 infants
followed up from birth to one year.
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colonization was reported to be as high as 100% amongst
60-day old Aboriginal infants [31].
This finding is comparable to data from the highlands of
Papua New Guinea, by 3 months all infants had acquired
S. pneumoniae [30]; whereas reports from other regions
suggest much longer times to first acquisition for S. pneu-
moniae; 50% colonization by 8 weeks in Bangladesh [32],
34% colonization by 6 months in Finland [33] and average
time to first detection of 6 months in the United States
[14]. However, as these studies were culture-based, it is yet
to be determined if the application of molecular tools
would result in earlier detection of S. pneumoniae and the
other pathogens.
Consistent with findings amongst Aboriginal and non-
Aboriginal infants in Western Australia [28], S. pneumo-
niae, H. influenzae and M. catarrhalis point prevalence
increased in the first few months of life. S. pneumoniae
carriage exceeded 80% by 12 weeks, which was also
reported in the larger cohort of 236 infants [11]. Although
S. aureus had the highest point prevalence amongst the
new-borns (> 50%) (Figure 1) and was acquired very
rapidly by most infants (Figure 2), the prevalence declined
to less than 20% by 9 weeks, similar to the report from
Western Australian [28]. High nasopharyngeal carriage of
S. aureus amongst the Gambian neonates may be linked
with the high burden invasive S. aureus disease in this age
group. S. aureus was the most frequently isolated patho-
gen amongst Gambian neonates (less than three months
old) with serious infections excluding meningitis [34]. This
finding has important implications for S. aureus vaccine
development and scheduling.
The introduction of the Hib polysaccharide-tetanus tox-
oid conjugate vaccine in 1997 saw Hib carriage among
Gambian children under five years drop from 12% to
0.25% (p < 0.01) [35-37]. In this study, Hib was found in
0.7% (95CI 0.5%, 0.9%) of the NP swabs and most H. influ-
enzae detected was non-typeable (Figure 1). Low levels of
carriage may explain why Hib is still responsible for a
small proportion of IBD amongst Gambian infants despite
widespread vaccination [26]. Low levels of Hib carriage in
the Gambia may provide a “boosting” effect within
the communities [38], preventing higher levels of re-
emergence disease. Continued Hib vaccination as well as
surveillance of Hib carriage and disease is of great impor-
tance in this region.
There is evidence of complex relationships between
pneumococci and other respiratory pathogens that co-
colonise the nasal and pharyngeal mucosae [39-41]. In this
study, we found that S. pneumoniae had a positive associa-
tion with H. influenzae and M. catarrhalis consistent with
previous reports [28,42]. The association between S. pneu-
moniae and H. influenzae remained significant after
adjusting for confounding factors. In contrast, the negative
association between S. pneumoniae and S. aureus was
reversed after adjusting for confounding factors. Although
there is evidence of direct interference mechanisms
between S. aureus and S. pneumoniae [43], host immune
function may play an important role in modulating the
association between these two pathogens [42].
The average prevalence of S. pneumoniae amongst the
infants using cpsA gene-based PCR detection was 78%
(95CI: 76%, 83%), very close to 79% (95CI: 75%, 82%)
which was previously determined by culture for the same
group of infants. S. pneumoniae was found in 36 (34%) of
the 106 culture-negative samples, however, it was not
detected in 34 (9%) of the 392 culture-positive samples
[11]. The cpsA primers used do not detect all pneumococ-
cal serotypes which could be accountable for the failed
detections [44]. Broth-enrichment prior to molecular ana-
lysis has been shown to improve the molecular detection
of low-density S. pneumoniae carriage [45]; however, it
needs to be determined if broth-enrichment would give
comparable enhancement for the other pathogens assayed.
The detection of S. pneumoniae in the culture-negatives
could be associated with the specificity of the cpsA gene
primers used; hence, the inclusion of an alternate gene
locus such as the autolysin gene (lytA) which has been
shown to have high specificity could be used to verify the
data presented here [46]. The samples were stored at
-70°C for up to five years prior to the molecular analysis.
Kwambana et. al., provided preliminary evidence that deep
frozen-storage of NP swabs in STGG may have differential
effects on the detection of some bacterial taxonomic
groups [47]. Hence, real time processing of nasopharyn-
geal swabs may be considered in future studies.
S. aureus had the lowest average prevalence among the
infants (< 20%). The low rates of detection could be in
part explained by the use of lysozyme for the extraction
of nucleic acids. Lysozyme does not effectively degrade
the S. aureus cell wall whereas the inclusion of lysosta-
phin has been shown to significantly improve the
PCR-based detection of S. aureus [48]. An important lim-
itation of using culture-independent molecular detection
of pathogens is that important antibiotic resistance data
cannot be determined.
Conclusions
The results of this study suggest that H. influenzae and
M. catarrhalis are ubiquitous inhabitants of the nasophar-
ynx which are acquired early and frequently co-carried
with S. pneumoniae in the Gambia. S. aureus prevalence is
high among neonates, which may be associated with the
high neonatal IBD burden in this region. This has impor-
tant potential implications for the aetiology of respiratory
polymicrobial infections, biofilm formation and vaccine
strategies.
PCV-7 which markedly reduces carriage of vaccine
and vaccine associated serotypes (> 60% of circulating
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pneumococci) in the Gambia is in widespread use [11].
A protein vaccine which may eliminate mucosal carriage
of both S. pneumoniae and H. influenzae is currently
under Phase 2 trials in the Gambia [49]. The effects
of these vaccines on pharyngeal microbial carriage, par-
ticularly the pathogens that share the niche with
S. pneumoniae, are yet to be described and warrant
more attention.
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